Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Topotecan × Clear all

Phase

Status

Completed 6 Terminated 3 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 CNS 1

Conditions

Small Cell Lung Carcinoma 10 Ovarian Neoplasms 7 Neuroblastoma 4 Retinoblastoma 3 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Wilms Tumor 1 Sarcoma, Ewing 1 SCLC 1 Recurrence 1 Pleuropulmonary blastoma 1 Peritoneal Neoplasms 1 Pediatric Brain Tumor 1 Neoplasms 1 Neoplasm Metastasis 1 Medulloblastoma 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Glioma 1 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 21 Temozolomide 15 Radiotherapy 9 Specimen Handling 7 Blood Specimen Collection 7 Radiation 6 Bevacizumab 5 pembrolizumab 3 olaparib 3 Surgical Procedures, Operative 3 Nivolumab 3 Magnetic Resonance Imaging 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 vorasidenib 2 trametinib 2 olutasidenib 2 lutetium Lu 177 dotatate 2 fluorodopa F 18 2 fludarabine 2 fluciclovine F-18 2 entrectinib 2 dabrafenib 2 contrast agent BR1 2 X-Rays 2 Watchful Waiting 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06666712 2026-04-15

TPT CED rHGG

Columbia University

Phase 1 Recruiting

Brain Neoplasms, Glioma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡